周邊血管介入市場規模、佔有率和成長分析（按介入類型、器械類型、適應症、技術、最終用戶和地區分類）- 產業預測（2026-2033 年）

預計到 2024 年，周邊血管介入市場規模將達到 111.3 億美元，到 2025 年將達到 121.4 億美元，到 2033 年將達到 243.7 億美元，在預測期（2026-2033 年）內，複合年成長率為 9.1%。

心血管疾病盛行率的上升是推動周邊血管介入治療需求成長的主要因素。高血壓、糖尿病、肥胖、吸菸和高碳水化合物攝取等風險因素顯著增加了各種心血管疾病的發生率。為此，全球範圍內導管介入檢查室的建設正在不斷擴展。這一趨勢在新興市場尤為顯著，這些市場中專攻此類手術的醫療專業人員數量正在增加。這種成長凸顯了導管介入檢查室在心血管疾病診斷和治療中的重要性，其應用正在加速，尤其是在發展中地區。混合型導管介入檢查室的出現也值得關注，它們能夠進行包括血管內介入和神經介入在內的多種臨床手術。總而言之，周邊血管介入治療日益專業化以及血管成形術等手術醫療費用支出的不斷成長，都預示著該行業將迎來強勁的成長。

周邊血管介入市場促進因素

心血管疾病，尤其是周邊動脈疾病（PAD）發生率的不斷上升，是推動周邊血管介入治療需求成長的主要因素。心血管疾病的激增受多種危險因子的影響，包括高血壓、糖尿病、肥胖和缺乏運動。隨著這些健康問題的日益普遍，對有效周邊血管治療的需求也隨之增加，凸顯了醫療技術和治療策略進步對於解決這些問題的關鍵意義。這種醫療重點的轉變不僅強調了控制現有疾病的重要性，也促進了旨在減輕心血管疾病整體負擔的預防和宣傳工作。

限制周邊血管介入市場發展的因素

周邊血管介入治療市場面臨許多限制因素，其中高昂的治療費用可能成為許多患者的障礙。在許多已開發地區，醫療成本負擔已成為患者獲得所需治療的一大障礙。醫療技術的日益複雜和進步進一步加劇了這個問題，因為這些往往意味著手術和治療費用的上漲。因此，經濟資源有限的患者難以獲得適當的醫療服務，最終限制了市場的整體成長潛力，並減少了能夠從這些重要的周邊血管介入治療中獲益的患者數量。

周邊血管介入市場趨勢

周邊血管介入市場的一大趨勢是建立綜合性導管檢查室，這些導管室整合了多種介入治療方法，包括心臟、血管、神經和電生理手術。這種向混合設施的轉變源於其多功能性、提供全面護理的能力，以及更高的手術效率和更好的患者預後。人們對這種適應性環境的日益青睞反映了治療模式的更廣泛轉變，使醫療服務提供者能夠提供滿足不同患者需求的多學科治療方法。隨著這些創新導管室的普及，預計它們將增強周邊血管介入市場，並推動技術和介入策略的進步。

目錄

介紹

• 分析目的
• 分析範圍
• 定義

分析方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場進行機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特五力分析

關鍵市場考量因素

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場魅力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球周邊血管介入市場規模及依介入類型分類的複合年成長率（2026-2033 年）

• 動脈粥狀硬化斑塊切除術
• 支架置入術
• 血管成形術
• 血栓切除術
• 栓塞術

全球周邊血管介入市場規模及按器械類型分類的複合年成長率（2026-2033 年）

• 導管
• 支架
• 導管導引線
• 氣球
• 栓塞線圈

全球周邊血管介入市場規模及依適應症分類的複合年成長率（2026-2033 年）

• 冠狀動脈疾病
• 中風
• 周邊動脈疾病
• 腎動脈狹窄
• 頸動脈狹窄

全球周邊血管介入市場規模及依技術分類的複合年成長率（2026-2033 年）

• 藥物釋放型支架
• 球囊擴張型支架
• 自動擴張型支架
• 旋切動脈粥狀硬化斑塊切除術
• 定向斑塊動脈粥狀硬化斑塊切除術

全球周邊血管介入市場規模及依最終用戶分類的複合年成長率（2026-2033 年）

• 醫院
• 門診手術中心
• 診所
• 研究所

全球周邊血管介入市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭格局

• 前五大公司對比
• 主要企業市場定位（2025 年）
• 主要企業採取的策略
• 近期市場趨勢
• 主要企業市佔率（2025 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 年比營收比較（2023-2025）

主要企業簡介

• 美敦力公司（愛爾蘭）
• 雅培實驗室（美國）
• 波士頓科學公司（美國）
• 貝克頓·迪金森公司（BD）（美國）
• Philips（Netherlands）
• 泰爾茂株式會社（日本）
• 庫克醫療（美國）
• 康德樂公司（美國）
• B.Braun Melsungen AG（德國）
• Getinge AB（瑞典）
• Merit Medical Systems, Inc.（美國）
• BIOTRONIK SE & Co. KG（德國）
• Endologix公司（美國）
• ArtVentive醫療Group Limited（美國）
• Inari Medical, Inc.（美國）
• Bentley InnoMed GmbH（德國）
• 戈爾醫療（美國）
• 微創醫療（中國）

結論與建議

Peripheral Interventions Market size was valued at USD 11.13 Billion in 2024 and is poised to grow from USD 12.14 Billion in 2025 to USD 24.37 Billion by 2033, growing at a CAGR of 9.1% during the forecast period (2026-2033).

The rising prevalence of cardiovascular disorders is a primary driver of demand for peripheral interventions. Contributing risk factors such as hypertension, diabetes, obesity, smoking, and high carbohydrate intake significantly increase the incidence of various cardiovascular diseases. In response, the establishment of catheterization laboratories is expanding globally, especially in emerging markets, alongside a growing number of healthcare professionals specializing in these procedures. This surge underscores the importance of cath labs for diagnosing and treating cardiovascular conditions, with their adoption particularly increasing in developing regions. The emergence of hybrid catheterization labs, which facilitate a range of clinical procedures including vascular and neurological interventions, is also notable. Overall, the increasing specialization in peripheral interventions and the rise in healthcare spending on procedures like angioplasties signal robust industry growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Interventions market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Interventions Market Segments Analysis

Global Peripheral Interventions Market is segmented by Intervention Type, Device Type, Indication, Technology, End User and region. Based on Intervention Type, the market is segmented into Atherectomy, Stent Implantation, Angioplasty, Thrombectomy and Embolization. Based on Device Type, the market is segmented into Catheters, Stents, Guide Wires, Balloons and Embolic Coils. Based on Indication, the market is segmented into Coronary Artery Disease, Stroke, Peripheral Arterial Disease, Renal Artery Stenosis and Carotid Artery Stenosis. Based on Technology, the market is segmented into Drug-Eluting Stents, Balloon-Expandable Stents, Self-Expanding Stents, Rotational Atherectomy and Directional Atherectomy. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, Clinics and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Peripheral Interventions Market

The increasing occurrence of cardiovascular diseases, particularly peripheral artery disease (PAD), significantly fuels the demand for peripheral interventions. This surge in cardiovascular conditions is influenced by various risk factors, including hypertension, diabetes, obesity, and a lack of physical activity. As these health issues become more widespread, the necessity for effective peripheral treatments grows, highlighting a crucial need for advancements in medical technologies and therapeutic strategies to address these concerns. This shift in healthcare focus not only emphasizes the importance of managing existing conditions but also encourages prevention and awareness initiatives aimed at reducing the overall burden of cardiovascular diseases.

Restraints in the Peripheral Interventions Market

The Peripheral Interventions market faces significant limitations due to the high costs associated with treatments, which can pose a barrier for many individuals seeking care. In many developed regions, the financial burden of healthcare can hinder patients from accessing necessary interventions. This situation is exacerbated by the complexity and advancements in medical technology, which often translate to higher prices for procedures and treatments. As a result, those with limited financial resources may struggle to receive appropriate care, ultimately restricting the overall growth potential of the market and limiting the number of patients who can benefit from these essential peripheral interventions.

Market Trends of the Peripheral Interventions Market

The Peripheral Interventions market is witnessing a significant trend towards the establishment of heterogeneous catheterization labs, which are increasingly integrating various invasive interventional treatments, including cardiac, vascular, neurological, and electrophysiological procedures. This shift towards hybrid facilities is driven by their versatility and the ability to deliver comprehensive care, enhancing procedural efficiency and patient outcomes. The growing preference for these adaptable environments reflects a broader transformation in treatment paradigms, enabling healthcare providers to offer multidisciplinary approaches that address diverse patient needs. As these innovative labs gain traction, they are set to strengthen the Peripheral Interventions market, fostering advancements in technology and interventional strategies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Peripheral Interventions Market Size by Intervention Type & CAGR (2026-2033)

• Market Overview
• Atherectomy
• Stent Implantation
• Angioplasty
• Thrombectomy
• Embolization

Global Peripheral Interventions Market Size by Device Type & CAGR (2026-2033)

• Market Overview
• Catheters
• Stents
• Guide Wires
• Balloons
• Embolic Coils

Global Peripheral Interventions Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Coronary Artery Disease
• Stroke
• Peripheral Arterial Disease
• Renal Artery Stenosis
• Carotid Artery Stenosis

Global Peripheral Interventions Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Drug-Eluting Stents
• Balloon-Expandable Stents
• Self-Expanding Stents
• Rotational Atherectomy
• Directional Atherectomy

Global Peripheral Interventions Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Research Institutes

Global Peripheral Interventions Market Size & CAGR (2026-2033)

• North America (Intervention Type, Device Type, Indication, Technology, End User)
  • US
  • Canada
• Europe (Intervention Type, Device Type, Indication, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Intervention Type, Device Type, Indication, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Intervention Type, Device Type, Indication, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Intervention Type, Device Type, Indication, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endologix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ArtVentive Medical Group, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inari Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bentley InnoMed GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gore Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations